CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 101 filers reported holding CARA THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 0.34 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $7,009,000 | +52.3% | 754,488 | +36.9% | 0.00% | 0.0% |
| Q3 2016 | $4,602,000 | +129.5% | 551,181 | +32.2% | 0.00% | – |
| Q2 2016 | $2,005,000 | -22.5% | 416,785 | +0.2% | 0.00% | – |
| Q1 2016 | $2,588,000 | -63.6% | 416,111 | -1.2% | 0.00% | -100.0% |
| Q4 2015 | $7,102,000 | +35.7% | 421,247 | +15.0% | 0.00% | 0.0% |
| Q3 2015 | $5,233,000 | +316.0% | 366,233 | +253.6% | 0.00% | – |
| Q2 2015 | $1,258,000 | +185.3% | 103,567 | +136.3% | 0.00% | – |
| Q1 2015 | $441,000 | +0.9% | 43,835 | +0.0% | 0.00% | – |
| Q4 2014 | $437,000 | +16.2% | 43,820 | -2.1% | 0.00% | – |
| Q3 2014 | $376,000 | -55.4% | 44,764 | -9.6% | 0.00% | – |
| Q2 2014 | $843,000 | -10.4% | 49,515 | -2.1% | 0.00% | – |
| Q1 2014 | $941,000 | – | 50,566 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 2,799,058 | $42,350,000 | 22.29% |
| Chescapmanager LLC | 1,314,603 | $19,890,000 | 2.42% |
| Prosight Management, LP | 294,041 | $4,449,000 | 2.06% |
| DAFNA Capital Management LLC | 261,442 | $3,956,000 | 1.18% |
| Cypress Capital Management LLC (WY) | 81,269 | $1,230,000 | 1.06% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 626,583 | $9,480,000 | 1.02% |
| Carmignac Gestion | 1,851,443 | $28,012,000 | 0.29% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,465,000 | $37,295,000 | 0.22% |
| Ikarian Capital, LLC | 301,700 | $4,565,000 | 0.20% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 689,899 | $10,438,000 | 0.20% |